Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter G Stock

Showing results (31-40 of 125) with videos related to

Pageof 13
Sort By:
Archives of Internal Medicine|August 13, 2003
Key clinical, ethical, and policy issues in the evaluation of the safety and effectiveness of solid organ transplantation in HIV-infected patientsMichelle E Roland, Bernard Lo, Jeffrey Braff, et al.
Journal of Pediatric Surgery|December 17, 2009
Long-term survival and renal transplantation in a monozygotic twin with cloacal dysgenesis sequenceRita A Mukhtar, Laurence S Baskin, Peter G Stock, et al.
The Journal of Clinical Investigation|June 18, 2021
Interpreting and addressing suboptimal immune responses after COVID-19 vaccination in solid-organ transplant recipientsPeter G Stock, Timothy J Henrich, Dorry L Segev, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 15, 2016
Liver transplant alone without kidney transplant for fibrinogen Aα-chain (AFib) renal amyloidosisOren K Fix, Peter G Stock, Brian K Lee, et al.
The AIDS Reader|January 2, 2007
Solid organ transplantation: referral, management, and outcomes in HIV-infected patientsMichelle E Roland, Laurie L Carlson, Lynda A Frassetto, et al.
Clinical Transplantation|July 14, 2016
Key donor factors associated with graft loss among liver transplant recipients with human immunodeficiency virusIsabel Campos-Varela, Jennifer L Dodge, Peter G Stock, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 13, 2005
Determinants of transplant surgeons' willingness to provide organs to patients infected with HBV, HCV or HIVScott D Halpern, David A Asch, Abraham Shaked, et al.
Human Immunology|August 25, 2016
Why do we have the kidney allocation system we have today? A history of the 2014 kidney allocation systemMark D Stegall, Peter G Stock, Kenneth Andreoni, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 22, 2006
Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantationNorah A Terrault, Jonathan T Carter, Laurie Carlson, et al.
Plos One|August 28, 2015
Immunologic Predictors of Liver Transplantation Outcomes in HIV-HCV Co-Infected PersonsAshwin Balagopal, Burc Barin, Jeffrey Quinn, et al.
Pageof 13

Showing results (31-40 of 125) with videos related to

Sort By:
Pageof 13
Archives of Internal Medicine|August 13, 2003
Key clinical, ethical, and policy issues in the evaluation of the safety and effectiveness of solid organ transplantation in HIV-infected patientsMichelle E Roland, Bernard Lo, Jeffrey Braff, et al.
Journal of Pediatric Surgery|December 17, 2009
Long-term survival and renal transplantation in a monozygotic twin with cloacal dysgenesis sequenceRita A Mukhtar, Laurence S Baskin, Peter G Stock, et al.
The Journal of Clinical Investigation|June 18, 2021
Interpreting and addressing suboptimal immune responses after COVID-19 vaccination in solid-organ transplant recipientsPeter G Stock, Timothy J Henrich, Dorry L Segev, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 15, 2016
Liver transplant alone without kidney transplant for fibrinogen Aα-chain (AFib) renal amyloidosisOren K Fix, Peter G Stock, Brian K Lee, et al.
The AIDS Reader|January 2, 2007
Solid organ transplantation: referral, management, and outcomes in HIV-infected patientsMichelle E Roland, Laurie L Carlson, Lynda A Frassetto, et al.
Clinical Transplantation|July 14, 2016
Key donor factors associated with graft loss among liver transplant recipients with human immunodeficiency virusIsabel Campos-Varela, Jennifer L Dodge, Peter G Stock, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 13, 2005
Determinants of transplant surgeons' willingness to provide organs to patients infected with HBV, HCV or HIVScott D Halpern, David A Asch, Abraham Shaked, et al.
Human Immunology|August 25, 2016
Why do we have the kidney allocation system we have today? A history of the 2014 kidney allocation systemMark D Stegall, Peter G Stock, Kenneth Andreoni, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 22, 2006
Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantationNorah A Terrault, Jonathan T Carter, Laurie Carlson, et al.
Plos One|August 28, 2015
Immunologic Predictors of Liver Transplantation Outcomes in HIV-HCV Co-Infected PersonsAshwin Balagopal, Burc Barin, Jeffrey Quinn, et al.
Pageof 13